New technologies to identify loci associated with diseases are enabling classification of diseases according to genetic 'architectures'. In this Review, the authors show that patients with seronegative and seropositive rheumatic diseases have distinct genetic signatures, enabling an alternative classification to serology and providing hope for personalizing medicine.
- Yohei Kirino
- Elaine F. Remmers
